Answers are grounded in this paper and cite their sources.
Background & Aims The sodium taurocholate co-transporting polypeptide (NTCP), the main hepatic uptake transporter of bile salts, is the docking receptor required for the hepatitis B and D virus (HBV/HDV) entry. The mechanism of NTCP-dependent internalization of HBV/HDV into hepatocytes is, however, unclear. We investigated the contribution of posttranslational modification of NTCP on transporter endocytosis and HBV infection. Methods NTCP ubiquitination was determined by immunoprecipitation of wild-type NTCP (NTCP WT ). Lysine residues (K) in the C-terminus were substituted by arginine (R) to identify ubiquitination sites. HepG2 cells overexpressing NTCP mutants were analysed for protein levels, bile salt uptake activity, NTCP endocytosis and HBV infectivity. Global ubiquitination inhibitor TAK-243 was used to study effects on uptake and HBV infection in NTCP WT -HepG2 and HepaRG cells. Sample sizes in the experiments were 3-10. Results NTCP is ubiquitinated. Compared to NTCP WT , the NTCP K340R mutant showed reduced ubiquitination, indicating K340 as the main ubiquitination target. Furthermore, NTCP K340R showed increased membrane abundance, which coincided with enhanced bile salt uptake (28.2±5.3 vs 74.4±5.8 pmol, p <0.0001). Compared to NTCP WT , NTCP K340R endocytosis was strongly impaired (100±47 vs 42±19%, p =0.0079) while HBV-derived myr-preS1 peptide binding was increased (100±33 vs 220±98%, p <0.0001). Compared to NTCP WT cells, HBV DNA content was strongly reduced in NTCP K340R cells (52.74±26.23 vs 7.22±3.28%, p =0.0022). In line with this, TAK-243 reduced cellular ubiquitination levels and increased the bile salt uptake (2,129±99.4 vs 4,631±180.3 pmol, p =0.0286), while reducing HBV DNA content in HepG2 (100±44 vs 18±13%, p <0.0001) and HepaRG cells (100±24 vs 65±6%, p =0.0483). Conclusions Lysine 340 is essential for NTCP ubiquitination. Inhibiting ubiquitination impaired NTCP endocytosis and reduced HBV infection, confirming NTCP-mediated endocytosis is critical for HBV hepatic entry.
No takes yet. Share an insight, caveat, or question.
Appelman et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: